expired2015-11-30
EFFICIENT REMOVAL OF LOW MOLECULAR WEIGHT NOM BY MORPHOLOGY CONTROLLED NANEX MEMBRANES
App 62260961
Built for decisionsEach workflow starts with a real patent-practice constraint.
Grounded in evidenceUSPTO, EPO, PatentsView, and OpenAlex data shape the analysis.
Designed end to endArchitecture, AI pipelines, product logic, and interface design.
01Portfolio intelligence
Patent Ranking Widget
Problem
In-house IP managers must make difficult decisions about which assets to retain during maintenance and annuity fee windows.
Solution
A data-driven score ranks each patent within the portfolio and benchmarks it against all issued patents, its filing-date cohort, and its CPC technology peer group.
- Overall portfolio percentile
- Filing-year cohort ranking
- CPC classification benchmark
Patent Rankings
CD6 antibody for treatment of T-cell mediated diseases or disorders
Overall Ranking
All Issued Patents
75th
Percentile
Rank
#923 of 3711
Score
0.47
By Filing Year Window
Filed 2019–2021
78th
Percentile
Rank
#252 of 1132
Score
0.47
By CPC Classification
CPC Section C
82th
Percentile
Rank
#137 of 764
Score
0.47
02AI-assisted prosecution
Office Action Analysis & Response Strategy
Problem
Reviewing new Office Actions, tracing specification support, and testing amendment language is slow, fragmented, and high stakes.
Solution
The workflow queries USPTO and EPO sources, parses the action, and prepares a detailed attorney-facing analysis with proposed amendments, cited-art distinctions, §112 risk, commercial effect, and response priority.
- Specification-linked amendment candidates
- Cited-art distinction analysis
- Commercial and §112 risk visibility
Proposed Amendment Candidates
Generated from the Office Action and specification
Figure-to-figure comparison
Application · FIG. 4
Cited reference · FIG. 7B
Novel geometry: integrated blocking element 115
Reference gap: separate upstream valve
Claim impact: supports spatial relationship limitation
Candidate / target
Proposed language
Specification support
Cited-art distinction
§112 risk
Commercial effect
Priority / likely response
A1: Single-reagent dual block
Claims 1, 3
Claims 1, 3
A single reagent comprising a biotin-binding protein and a peroxidase-blocking reagent, blocking endogenous biotin and peroxidase activity during the same treatment.
express
Specification support identifies simultaneous reaction with a single reagent.
Molecular Probes; DeMonte et al.
References do not disclose an IHC workflow combining both blocking functions in one treatment.
Low
Moderate
Priority 1
May require RCE/search; argues non-obvious combination.
Specification-linked support and cited-art distinctions remain visible for attorney review.
03Cost management
Patent Cost Projections
Problem
Portfolio owners need a defensible view of future prosecution and maintenance spend before budget decisions are locked.
Solution
Art-unit timelines built from more than 3 million Office Actions support patent-level and portfolio-level spend projections, customized to each user's cost structure.
- Maintenance fee forecasting
- Office Action response costs
- Issue fee and PCT planning
Patent Cost Projections
Current portfolio maintenance and prosecution forecast
Grand Total
$118K
- Non-Final OA
- Est. Non-Final OA
- Final OA
- Issue Fee
- PCT Conversion
- Maintenance Fee
04Portfolio architecture
Inventor Portfolio Trees
Problem
Complex continuation families are difficult to understand in flat tables, especially across inventors and technology groups.
Solution
Interactive family trees reveal lineage, status, and relationships across complex portfolios. Users can drag and drop nodes, reposition families, and draw connections directly on the canvas.
- Interactive drag-and-drop nodes
- Inventor and technology views
- Continuation-family relationships
Inventor Portfolio Continuity Map
Three patent families · 12 applications · drag nodes, pan, and zoom
Interactive: drag any application card to reorganize the family tree
Family 1
Family 2
Family 3
expired2015-11-30
EFFICIENT REMOVAL OF LOW MOLECULAR WEIGHT NOM BY MORPHOLOGY CONTROLLED NANEX MEMBRANES
App 62260948
pct2016-11-30
NANOMATERIALS, DEVICES, AND METHODS OF WATER TREATMENT
App PCTUS1664203
patented2018-05-30
NANOMATERIALS, DEVICES, AND METHODS OF WATER TREATMENT
App 15779990US 11542181
expired2017-12-04
NANORESIN COMPOSITE FOR WATER PURIFICATION
App 62594085
pct2018-12-04
SEPARATION MEDIA, DEVICES AND APPLICATIONS THEREOF
App PCTUS1863850
patented2020-05-29
SEPARATION MEDIA, DEVICES AND APPLICATIONS THEREOF
App 16768344US 12128394
patented2024-10-28
SEPARATION MEDIA, DEVICES AND APPLICATIONS THEREOF
App 18928603US 12434232
expired2020-08-14
AQUEOUS SYNTHESIS OF POLYMER FUNCTIONALIZED GRAPHENIC MATERIALS
App 63065669
expired2021-05-20
AQUEOUS SYNTHESIS OF POLYMER FUNCTIONALIZED CELLULOSIC MATERIALS
App 63190994
pct2021-08-13
NANOCOMPOSITE SEPARATION MEDIA AND METHODS OF MAKING THE SAME
App PCTUS2145915
pending2023-02-10
NANOCOMPOSITE SEPARATION MEDIA AND METHODS OF MAKING THE SAME
App 18020694
Connected IP intelligence
Engineering Practice Through Intelligence.
Purpose-built systems connect prosecution history, portfolio performance, research signals, and financial planning to the decisions IP teams make every day.
05
Examiner Intelligence & Benchmarking
Built from more than three million First Office Actions, this module benchmarks allowance, final-rejection, RCE, and interview outcomes against art-unit and technology-center medians.
Examiner K. Nguyen · AU 2491
vs. Art Unit medianAllowance Rate48%
Final Rejection Rate61%
Avg. RCEs to Allowance1.8
Interview Success74%
Art unit median · colored bar = this examiner
06
Invention Scout & Funding Discovery
Fresh research is ranked for patentability and matched to relevant non-dilutive funding.
91
Solid-State Electrolyte Interface Coating
Nature Energy · 2 wks ago
88
NSF PFI — Translational R&D
Deadline in 34 days
84
Adaptive Neural Compression Method
NeurIPS · 5 days ago
07
Executive Portfolio Reporting
Audience-ready drafts translate portfolio health, spend, citation momentum, deadlines, and recommended actions for executives, legal teams, and finance leaders.
Weekly Portfolio Brief · Executive
Subject
Three portfolio decisions requiring attention
Portfolio activity remains on plan, with three decisions requiring leadership attention this week.
Recommended actions
1. Approve $184K Q4 prosecution reserve
2. Review two licensing candidates
3. Escalate one deadline due Friday
08
Portfolio Ranking by Technology
The homepage ranking view plots every asset by portfolio rank on the y-axis and organizes it by named technology cluster.
Portfolio Rank by Technology Cluster
Each point represents a patent ranked within its technology group
100500
Portfolio Rank